[THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2021]

Arerugi. 2022;71(10):1201-1206. doi: 10.15036/arerugi.71.1201.

[Article in Japanese]

Author

Hidehisa Saeki¹

Affiliation

¹ Department of Dermatology, Nippon Medical School.

PMID: 36543197
DOI: 10.15036/arerugi.71.1201

No abstract available

Keywords: atopic dermatitis; baricitinib; delgocitinib; dupilumab; topical steroid.

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatitis, Atopic* / therapy
Humans
Treatment Outcome

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized